Pharmaceutical Companies

Monopar Therapeutics

Country: 🇺🇸United States

Ownership: -

Established: -

Employees: 10

Market Cap: $8.4M

Website: -

Monopar Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in developing proprietary therapeutics for cancer patients. It also focuses on building a drug development pipeline through the licensing, and acquisition of therapeutics in late preclinical and clinical development stages. The company was founded by Chandler Drew Robinson, Christopher M. Starr and Andrew P. Mazar in December...

Monopar Therapeutics

🇺🇸United States

Ownership: -

Established: -

Employees: 10

Market Cap: $8.4M

Website: -

Tonix Pharmaceuticals, Inc.

Country: 🇺🇸United States

Ownership: Subsidiary

Established: -

Employees: -

Market Cap: $7.9M

Website: -

Tonix Pharmaceuticals, Inc.

🇺🇸United States

Ownership: Subsidiary

Established: -

Employees: -

Market Cap: $7.9M

Website: -

Pulmatrix

Country: 🇺🇸United States

Ownership: Public

Established: 2003-01-01

Employees: 22

Market Cap: $7.5M

Website: http://www.pulmatrix.com

Pulmatrix

🇺🇸United States

Ownership: Public

Established: 2003-01-01

Employees: 22

Market Cap: $7.5M

Website: http://www.pulmatrix.com

Allup Silica Ltd

Country: 🇨🇦Canada

Ownership: -

Established: -

Employees: 42

Market Cap: $7.1M

Website: -

Aptose Biosciences Inc is a clinical-stage biotechnology company committed to discovering and developing personalized therapies addressing unmet medical needs in oncology. The Company's small molecule cancer therapeutics pipeline includes products designed to provide single agent efficacy and to enhance the efficacy of other anti-cancer therapies and regimens without overlapping toxicities.

Allup Silica Ltd

🇨🇦Canada

Ownership: -

Established: -

Employees: 42

Market Cap: $7.1M

Website: -

Oragenics, Inc.

Country: 🇺🇸United States

Ownership: Public

Established: 1996-01-01

Employees: 11

Market Cap: $7M

Website: http://www.oragenics.com

Oragenics, Inc.

🇺🇸United States

Ownership: Public

Established: 1996-01-01

Employees: 11

Market Cap: $7M

Website: http://www.oragenics.com

Talis Biomedical Corp

Country: 🇺🇸United States

Ownership: -

Established: 2008-01-01

Employees: -

Market Cap: $7M

Website: https://www.oecd.org/education/talis/

Talis Biomedical Corp

🇺🇸United States

Ownership: -

Established: 2008-01-01

Employees: -

Market Cap: $7M

Website: https://www.oecd.org/education/talis/

Cyclerion Therapeutics

Country: 🇺🇸United States

Ownership: Public

Established: -

Employees: 1

Market Cap: $6.9M

Website: http://www.cyclerion.com

Cyclerion Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of human therapeutics. Its product pipeline includes several sGC stimulators, small molecules that act synergistically with nitric oxide on sGC to boost production of cyclic guanosine monophosphate. The company was founded on September 6, 2018 and is headquartered in...